Directory
>
Bill Mroczka Jd
Bill Mroczka Jd
Vice President, US Market Access | Ani Pharmaceuticals, Inc.
Chicago, Illinois, United States
Bill Mroczka Jd
Summary
Bill Mroczka is a seasoned leader in the pharmaceutical industry with extensive experience in market access, particularly in specialty therapies and rare diseases. He has a proven track record of successfully launching products and establishing payer relationships that enhance access to innovative treatments. Bill's strategic mindset and ability to navigate complex market dynamics have enabled him to secure significant payer coverage rapidly. His expertise spans various therapeutic areas, including oncology, endocrinology, and gene therapy, showcasing his versatility. Bill is also recognized for his excellent communication skills and cross-functional leadership capabilities, making him a valuable asset in any organization. With a strong educational background in law and business, he combines legal acumen with commercial insights to drive business success.
Bill Mroczka Jd
Work Experience
Vice President, US Market Access at
Ani Pharmaceuticals, Inc.
May 2021 - Present
Senior Director, US Market Access at bluebird bio at
bluebird bio
May 2019 - May 2021
Director, National US Market Access and Reimbursement at
Alexion Pharmaceuticals, Inc.
April 2016 - May 2019
Senior National Account Executive, Specialty Channel at
Takeda Pharmaceuticals America, Inc.
December 2014 - March 2016
Sr. Corporate Account Director at
AbbVie
June 2003 - November 2014
Sr. Product Manager CNS and Respiratory at
MedPointe Pharmaceuticals
September 2001 - May 2003
National Account Manager at
MedPointe Pharmaceuticals
October 1998 - April 2001
Professional Medical Sales Representative at
Wallace Pharmaceuticals
June 1993 - September 1997
Bill Mroczka Jd
Education
University of Illinois Chicago School of Law, Jd
January 1995 - January 2000
Loyola University Chicago, Bba
January 1991 - January 1993
Frequently Asked Questions about Bill Mroczka Jd
What is Bill Mroczka Jd email address?
Bill Mroczka Jd's primary email address is ************@anipharmaceuticals.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Bill Mroczka Jd work for?
Bill Mroczka Jd is a Vice President, US Market Access at Ani Pharmaceuticals, Inc., a company specializing in Pharmaceutical & Medicine Manufacturing.
Where Bill Mroczka Jd graduated from?
Bill Mroczka Jd holds a degree in Food And Drug Law from University of Illinois Chicago School of Law.
How can I directly contact Bill Mroczka Jd?
To contact Bill Mroczka Jd directly, you can use the email address ************@anipharmaceuticals.com. Complete contact information is available upon registration with Muraena.
Who is Bill Mroczka Jd?
Bill Mroczka is a seasoned leader in the pharmaceutical industry with extensive experience in market access, particularly in specialty therapies and rare diseases. He has a proven track record of successfully launching products and establishing payer relationships that enhance access to innovative treatments. Bill's strategic mindset and ability to navigate complex market dynamics have enabled him to secure significant payer coverage rapidly. His expertise spans various therapeutic areas, including oncology, endocrinology, and gene therapy, showcasing his versatility. Bill is also recognized for his excellent communication skills and cross-functional leadership capabilities, making him a valuable asset in any organization. With a strong educational background in law and business, he combines legal acumen with commercial insights to drive business success.
Bill`s contact details
************@anipharmaceuticals.com
************@allergan.com
Colleagues
Vice President, Human Resources
Executive Chairman
Senior Vice President
VP, Corporate Controller
Vice President, Operations---Rare Disease
Vice President, Patient Support
Senior Vice President, Finance and Chief Financial Officer
Vice President Of Product Development
SVP, General Counsel and Corporate Secretary
Senior Vice President, Operations